References
- World Health Organization. Hepatitis A. 2010. http://www.who.int/mediacentre/factsheets/fs328/en/index.html (accessed 2 June 2013).
- RCGP. Being a General Practitioner. RCGP: London; 2012. Available at http://www.rcgp-curriculum.org.uk/PDF/curr_1_Curriculum_Statement_Being_a_GP.pdf (accessed 5 February 2013).
- Moberley S, Holden J, Tatham D, Andrews R. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2013;1:CD000422.
- Sackett D. Becoming a successful clinician-investigator. In: Haynes B, Sackett D, Gyatt G, Tugwell P, editors. Clinical epidemiology: How to do clinical practice research. 3rd ed. London: Lippincott Williams & Wilkins; 2005. pp. 415.
- The Cochrane Collaboration. Review groups. Available at http//.www.cochrane.org/contact/review-groups (accessed 2 July 2013).
- Cochrane Hepato-biliary Group. Available at http://hbg.cochrane.org (accessed 7 February 2013).
- The Cochrane handbook for systematic reviews of interventions version 5.1. Available at http://www.cochrane-handbook.org (accessed 7 February 2013).
- Xu Z, Wang X, Li R, Meng Z, Zhang Y, Gong J, et al. Immunogenicity and efficacy of two live attenuated hepatitis A vaccines (H(2) strains and LA-1 strains). Zhonghua Yi Xue Za Zhi 2002;82:678–81.
- Li Y, Wu H, Xu T. Observation of immunogenicity and epidemiological efficacy assessment of attenuated live hepatitis A vaccine. Chi J Pub Health 2000;16:737–38.
- Irving G, Holden J, Pope D, Yang R. Systematic review of the protective efficacy of hepatitis A vaccines. 17th Wonca Europe Conference 2011; Warsaw. Available at http://www.nivel.nl/pdf/WONCA_Programme%202011.pdf (accessed 7 February 2013).
- MacAuley D. 17th Wonca Europe Conference, Warsaw. Available at http://blogs.bmj.com/bmj/2011/09/16/domhnall-macauley-17th-wonca-europe-conference-warsaw/ (accessed 7 February 2013).
- Watts G. Data rising from the East. Br Med J. 2011;343:e861.
- Wiersma S, Irving G, Ott J, Holden J. WHO GRADE tables: Full dose inactivated hepatitis A vaccine 1992. Available at http://www.who.int/immunization/sage/2_GRADETables1a_d_EfficSafety_14Oct_nov11.pdf (accessed 7 February 2013).
- World Health Organization. Evidence based recommendations for use of hepatitis A vaccines in immunization services: Background paper for SAGE discussions 2011. Available at http://www.who.int/immunization/sage/meetings/2012/april/1_HepABackground_17Oct_final2_nov11.pdf (accessed 7 February 2013).
- World Health Organization. Meeting of the strategic advisory group of experts on immunization, 2012—conclusions and recommendations. Wkly Epidemiol Rec 2011;21;87:201–16.
- Ott J, Irving G, Wiersma S. Long-term protective effects of hepatitis A vaccines. A systematic review. Vaccine. 2012;31:3–11. doi:10.1016/j.vaccine.2012.04.104. Epub 2012 May 17.
- Irving G, Holden J, Yang R, Pope D. Hepatitis A immunisation in persons not previously exposed to hepatitis A. Cochrane Database Syst Rev. 2012;7: CD009051.
- Wikipedia. Hepatitis A vaccines. Secondary hepatitis A vaccines 2011. http://en.wikipedia.org/wiki/Hepatitis_A_vaccine (accessed 7 February 2013).
- Cochrane Primary Health Care Field. Available at http://www.cochraneprimarycare.org/ (accessed 7 February 2013).